ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

QNRX Quoin Pharmaceuticals Ltd

0.7502
0.00 (0.00%)
시간외 단일가
최종 업데이트: 18:50:58
15분 지연
기업명 주식 심볼 시장 주식 타입
Quoin Pharmaceuticals Ltd QNRX 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.7502 18:50:58
개장가 저가 고가 종가 전일 종가
0.7502
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/05/202405:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/05/202421:30GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
09/05/202405:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/05/202405:10GLOBEQuoin Pharmaceuticals to Announce First Quarter 2024..
14/03/202405:05GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
13/03/202420:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
09/03/202406:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/03/202406:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/03/202406:01EDGAR2Form 8-K - Current report
08/03/202406:05GLOBEQuoin Pharmaceuticals Announces Fourth Quarter and 2023..
07/03/202407:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
07/03/202406:01EDGAR2Form 8-K - Current report
05/03/202422:00GLOBEQuoin Pharmaceuticals Announces Pricing of $6.5 Million..
05/03/202407:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/03/202422:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Recruit..
27/02/202420:01EDGAR2Form DEF 14A - Other definitive proxy statements
15/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
14/02/202410:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:50EDGAR2Form S-1/A - General form for registration of securities..
14/02/202406:30EDGAR2Form PRE 14A - Other preliminary proxy statements
13/02/202407:12EDGAR2Form S-1 - General form for registration of securities under..
08/02/202422:00GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
31/01/202406:05EDGAR2Form 8-K - Current report
19/12/202307:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/12/202307:29EDGAR2Form 8-K - Current report
13/12/202322:30GLOBEQuoin Pharmaceuticals Announces FDA Clearance of Clinical..
10/11/202307:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/11/202307:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202307:10EDGAR2Form 8-K - Current report
09/11/202307:46GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
08/11/202307:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/11/202306:17EDGAR2Form 8-K - Current report
03/11/202321:41GLOBEQuoin Pharmaceuticals Announces Third Quarter 2023 Financial..
02/11/202306:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/11/202305:59EDGAR2Form 8-K - Current report
31/10/202305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202305:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202305:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202322:32GLOBEREPEAT -- Quoin Pharmaceuticals Announces Additional..
24/10/202321:28GLOBEQuoin Pharmaceuticals Announces Additional Positive Clinical..
20/10/202306:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/09/202305:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/09/202319:03EDGAR2Form DEF 14A - Other definitive proxy statements
02/09/202302:38EDGAR2Form PRE 14A - Other preliminary proxy statements
04/08/202305:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/08/202303:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/202306:01EDGAR2Form 8-K - Current report
03/08/202305:45GLOBEQuoin Pharmaceuticals Provides Corporate Update and..